Arsenite inhibits two steps in the ubiquitin-dependent proteolytic pathway.
Eukaryotic cells possess a multienzyme ATP-dependent proteolytic pathway in which the small, highly conserved protein ubiquitin (Ub) acts as a cofactor. In this pathway, formation of a covalent Ub-substrate conjugate precedes ATP-dependent degradation of the substrate. Inorganic arsenite (AsO2-) inhibited Ub-dependent protein degradation in a concentration-dependent fashion, both in intact rabbit reticulocytes and in a reticulocyte lysate (fraction II). Concentrations of arsenite causing half-maximal inhibition in fraction II varied with the substrate, ranging from 0.025 mM (bovine alpha-lactalbumin) to 3.3 mM (reduced/carboxymethylated bovine serum albumin). Inhibition was rapidly reversed upon addition of dithiothreitol. Arsenite inhibited the Ub-dependent proteolytic pathway at one or both of two steps, depending on the substrate. 1) Proteins with acidic amino termini must be amino terminally arginylated, in a tRNA-dependent reaction, prior to becoming conjugated to Ub (Ferber, S., and Ciechanover, A. (1987) Nature 326, 808-811). Arsenite inhibited substrate arginylation, and therefore also inhibited Ub conjugation. The inhibited species appeared to be arginyl aminoacyl-tRNA transferase, since arsenite was without strong effect on the rate or extent of arginyl-tRNA formation in fraction II, yet almost completely inhibited arginine transfer from arginyl-tRNA to reduced/carboxymethylated bovine serum albumin. 2) Arsenite also inhibited Ub-substrate conjugate turnover, as shown in pulse-chase experiments. For a given substrate, degradative (protease-dependent) and Ub regenerative (isopeptidase-dependent) components of conjugate turnover were similarly inhibited by arsenite. The potency of this inhibition varied for different substrates. Monosubstituted trivalent arsenicals such as arsenite typically interact with sites containing vicinal sulfhydryl groups. Inhibition by arsenite of two steps in the Ub-dependent proteolytic pathway suggests that the relevant pathway components could possess this kind of structural/catalytic feature.
Klemperer
N S
NS
Department of Biochemistry, State University of New York, Buffalo 14214.
Pickart
C M
CM
D000255:Adenosine Triphosphate / Q000097:blood*; D000818:Animals; D001151:Arsenic / Q000494:pharmacology*; D018053:Arsenites; D001798:Blood Proteins / Q000378:metabolism*; D005914:Globins / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D007700:Kinetics; D007768:Lactalbumin / Q000378:metabolism; D011817:Rabbits; D012156:Reticulocytes / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000378:metabolism; D014452:Ubiquitins / Q000097:blood*
D018053:Arsenites; D001798:Blood Proteins; D014452:Ubiquitins; D012710:Serum Albumin, Bovine; D000255:Adenosine Triphosphate; D005914:Globins; D007768:Lactalbumin; C015001:arsenite; D001151:Arsenic